Barinthus Biotherapeutics (BRNS) Short Interest Ratio & Short Volume $0.68 +0.05 (+7.05%) Closing price 05/19/2026 04:00 PM EasternExtended Trading$0.67 -0.02 (-2.27%) As of 05/19/2026 07:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Barinthus Biotherapeutics Short Interest OverviewAs of April 30, 2026, Barinthus Biotherapeutics (BRNS) had a short interest of 7,742 shares sold short, representing 0.02% of the public float. This marks a -6.00% decrease in short interest since the prior report. The short interest ratio (days to cover) is 0.4, meaning it would take 0.4 days of the average trading volume of 22,288 shares to cover all short positions.Current Short Interest7,742 sharesPrevious Short Interest8,236 sharesChange Vs. Previous Month-6.00%Dollar Volume Sold Short$5.03 thousandShort Interest Ratio0.4 Days to CoverLast Record DateApril 30, 2026Outstanding Shares40,850,000 sharesShort Percent of Float0.02%Today's Trading Volume19,536 sharesAverage Trading Volume22,288 sharesToday's Volume Vs. Average88% Short Selling Barinthus Biotherapeutics? Sign up to receive the latest short interest report for Barinthus Biotherapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBRNS Short Interest Over TimeBRNS Days to Cover Over TimeBRNS Percentage of Float Shorted Over Time Barinthus Biotherapeutics Tesla Short Interest History & Recent Changes ExportReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20267,742 shares $5.03 thousand -6.0%0.0%0.41 $0.65 4/15/20268,236 shares $4.88 thousand -21.3%0.0%0.45 $0.59 3/31/202610,469 shares $6.02 thousand +101.0%0.0%0.23 $0.58 3/13/20265,208 shares $3.28 thousand -35.2%0.0%0.3 $0.63 2/27/20268,036 shares $4.69 thousand +816.3%0.0%0.09 $0.58 2/13/2026877 shares $551.63 -38.8%0.0%0.02 $0.63 1/30/20261,434 shares $1.05 thousand -73.7%0.0%0.06 $0.73 1/15/20265,444 shares $3.97 thousand -27.2%0.0%0.1 $0.73 12/31/20257,478 shares $5.24 thousand +72.8%0.0%0.1 $0.70 12/15/20254,327 shares $3.20 thousand -52.4%0.0%0.05 $0.74 Get the Latest News and Ratings for BRNS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Barinthus Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/28/20259,085 shares $7.45 thousand -72.4%0.0%0.08 $0.82 11/14/202532,865 shares $26.13 thousand -19.1%0.1%0.18 $0.80 10/31/202540,612 shares $53.49 thousand +18.6%0.1%0.81 $1.32 10/15/202534,300 shares $46.99 thousand -72.1%0.1%0.3 $1.37 9/30/2025123,100 shares $153.88 thousand +53.5%0.3%0.1 $1.25 9/15/202580,200 shares $84.21 thousand +498.5%0.2%0.1 $1.05 8/31/202513,400 shares $15.06 thousand +8.9%0.0%0 $1.12 8/15/202512,300 shares $15.44 thousand -70.4%0.0%0 $1.26 7/31/202541,600 shares $61.57 thousand +36.8%0.1%0 $1.48 7/15/202530,400 shares $31.01 thousand +1.7%0.1%0 $1.02 6/30/202529,900 shares $27.81 thousand -9.7%0.1%0.9 $0.93 6/15/202533,100 shares $29.90 thousand -15.8%0.1%1 $0.90 5/31/202539,300 shares $41.66 thousand +10.1%0.1%1.2 $1.06 5/15/202535,700 shares $31.06 thousand -31.9%0.1%1.1 $0.87 4/30/202552,400 shares $58.69 thousand +211.9%0.1%1.9 $1.12 4/15/202516,800 shares $11.44 thousand +60.0%0.1%0.6 $0.68 3/31/202510,500 shares $10.21 thousand -29.1%0.0%0.3 $0.97 3/15/202514,800 shares $15.69 thousand +31.0%0.0%0.4 $1.06 2/28/202511,300 shares $11.41 thousand -19.9%0.0%0.3 $1.01 2/15/202514,100 shares $15.37 thousand +3.7%0.0%0.3 $1.09 1/31/202513,600 shares $14.48 thousand -46.5%0.0%0.2 $1.07 1/15/202525,400 shares $25.91 thousand +104.8%0.1%0.5 $1.02 12/31/202412,400 shares $14.98 thousand +134.0%0.0%0.2 $1.21 12/15/20245,300 shares $4.84 thousand -61.9%0.0%0.1 $0.91 11/30/202413,900 shares $13.71 thousand +18.8%0.0%0.3 $0.99 11/15/202411,700 shares $11.35 thousand +39.3%0.0%0.3 $0.97 10/31/20248,400 shares $12.52 thousand +110.0%0.0%0.3 $1.49 10/15/20244,000 shares $4.80 thousand -13.0%0.0%0.1 $1.20 9/30/20244,600 shares $5.66 thousand -23.3%0.0%0.2 $1.23 9/15/20246,000 shares $7.62 thousand +3.5%0.0%0.3 $1.27I’m sounding the alarm (Ad)Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, Amazon, Snap, and Block have done the same. Most assume this is about AI - but investor Porter Stansberry says the real driver runs far deeper. Goldman Sachs estimates 12,400 Americans are being financially harmed every day by this shift, while others grow wealthier. Stansberry - who predicted the internet economy's rise and recommended Amazon, Qualcomm, and Texas Instruments before they were household names - is now releasing a new investigation he calls The Final Displacement.Watch Stansberry's full investigation and see which companies to buy and sell 8/31/20245,800 shares $7.63 thousand -40.2%0.0%0.2 $1.32 8/15/20249,700 shares $12.61 thousand -34.5%0.0%0.4 $1.30 7/31/202414,800 shares $22.05 thousand -50.3%0.0%0.6 $1.49 7/15/202429,800 shares $46.04 thousand +223.9%0.1%1.2 $1.55 6/30/20249,200 shares $12.88 thousand +27.8%0.0%0.4 $1.40 6/15/20247,200 shares $13.18 thousand +24.1%0.0%0.3 $1.83 5/31/20245,800 shares $11.08 thousand -36.3%0.0%0.2 $1.91 5/15/20249,100 shares $20.20 thousand -52.1%0.0%0.4 $2.22 4/30/202419,000 shares $38.95 thousand +34.8%0.1%0.8 $2.05 4/15/202414,100 shares $37.25 thousand +39.6%0.0%0.6 $2.64 3/31/202410,100 shares $24.04 thousand -15.1%0.0%0.5 $2.38 3/15/202411,900 shares $29.39 thousand -3.3%0.0%0.8 $2.47 2/29/202412,300 shares $34.81 thousand -12.8%0.0%0.8 $2.83 2/15/202414,100 shares $34.97 thousand -55.8%0.0%1.2 $2.48 1/31/202431,900 shares $87.73 thousand No Change0.1%1.3 $2.75 BRNS Short Interest - Frequently Asked Questions What is Barinthus Biotherapeutics' current short interest? Short interest is the volume of Barinthus Biotherapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 7,742 shares of BRNS short. 0.02% of Barinthus Biotherapeutics' shares are currently sold short. Learn More on Barinthus Biotherapeutics' current short interest. What is a good short interest ratio for Barinthus Biotherapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BRNS shares currently have a short interest ratio of 0.4. Learn More on Barinthus Biotherapeutics's short interest ratio. What is a good short interest percentage for Barinthus Biotherapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.02% of Barinthus Biotherapeutics' floating shares are currently sold short. Is Barinthus Biotherapeutics' short interest increasing or decreasing? Barinthus Biotherapeutics saw a drop in short interest during the month of April. As of April 30th, there was short interest totaling 7,742 shares, a drop of 6.0% from the previous total of 8,236 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Barinthus Biotherapeutics' short interest compare to its competitors? 0.02% of Barinthus Biotherapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Barinthus Biotherapeutics: Kalaris Therapeutics Inc. (10.99%), Cognition Therapeutics, Inc. (10.43%), Biomea Fusion, Inc. (24.34%), Coya Therapeutics, Inc. (4.00%), enGene Holdings Inc. (3.34%), Aldeyra Therapeutics, Inc. (13.34%), Cypherpunk Technologies (9.46%), Oncolytics Biotech Inc. (6.27%), Q32 Bio Inc. (6.42%), NRx Pharmaceuticals, Inc. (14.24%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks. What does it mean to sell short Barinthus Biotherapeutics stock? Short selling BRNS is an investing strategy that aims to generate trading profit from Barinthus Biotherapeutics as its price is falling. BRNS shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Barinthus Biotherapeutics? A short squeeze for Barinthus Biotherapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BRNS, which in turn drives the price of the stock up even further. How often is Barinthus Biotherapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BRNS, twice per month. The most recent reporting period available is April, 30 2026. What do BRNs' short interest metrics mean? Understanding short interest metrics can help you assess how traders are positioning around a stock like BRNS:Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity. More Short Interest Resources from MarketBeat Related Companies Kalaris Therapeutics Short Interest Data Cognition Therapeutics Short Interest Data Biomea Fusion Short Interest Data Coya Therapeutics Short Interest Data enGene Short Interest Data Aldeyra Therapeutics Short Interest Data Cypherpunk Technologies Short Interest Data Oncolytics Biotech Short Interest Data Q32 Bio Short Interest Data NRx Pharmaceuticals Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BRNS) was last updated on 5/20/2026 by MarketBeat.com Staff. From Our PartnersI’m sounding the alarmMeta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...Porter & Company | SponsoredYour book attachedVeteran trader Bill Poulos is giving away his 'Simple Options Trading For Beginners' book - normally $29.97 - ...Profits Run | SponsoredThe one number Musk can't hide in the S-1When SpaceX files its S-1 in June, one number will stand out - power consumption. Running 1 million GPUs requi...Behind the Markets | SponsoredHe doesn't buy gold. He just profits from it.Former hedge fund manager Larry Benedict generated $274 million in profits - and Barron's ranked his fund in t...Brownstone Research | SponsoredHow to Access Elon’s “Monster” Interest RateMost Americans earn just 0.4% on their savings - that's $40 a year on $10,000. A new banking alternative is of...InvestorPlace | SponsoredThe “tell” for the end of the AI boomThe real question about AI stocks in 2026 isn't whether to own them - it's knowing exactly when to get in and ...Stansberry Research | SponsoredBIGGER than the SpaceX IPO?Jon Najarian believes the SpaceX IPO - potentially arriving as soon as June 12th - may not even be the biggest...Banyan Hill Publishing | SponsoredAfter June 1, don't say I didn't warn youMacroeconomic Strategist Dr. Mark Skousen of The Oxford Club says one date should be at the top of every inves...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Barinthus Biotherapeutics PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Barinthus Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
